Cavan Reilly

10.1k citations
146 papers · 8.3k · 5 hit papers · h-index 44

Impact in

  • Virology top 0.1%
    • HIV Research and Treatment
    • HIV/AIDS drug development and treatment
    • SARS-CoV-2 and COVID-19 Research

Papers in

    • HIV Research and Treatment 43
    • Viral Infections and Outbreaks Research 18
    • COVID-19 Clinical Research Studies 11
    • HIV/AIDS drug development and treatment 6
    • HIV/AIDS Research and Interventions 6

Cavan Reilly

142 papers receiving 8.1k citations

Cavan Reilly's Hit Papers

Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial 2022 · 161 citations
1610+7+14Years since publication250500750

Peers

Cavan Reilly
Comparison fields: 5 of 158
  • Virology 3.9k
  • Infectious Diseases 1.1k
  • Periodontics 294
  • Immunology 848
  • Ophthalmology 235
Replace Gene M. Shearer with:
Gene M. Shearer United States
Julia A. Metcalf United States
Jeffrey M. Jacobson United States
David J. Kelvin Canada
Gustavo Reyes‐Terán Mexico
Shinichi Oka Japan
Britta Wahrén Sweden
Alvin E. Friedman‐Kien United States
C Griscelli France
Luis J. Montaner United States
Cavan Reilly relative to Gene M. Shearer United States Gene M. Shearer's profile →
Citations per field
00.5×2×4×5.4×
Gene M. Shearer · 1×
Citations per year

Countries citing papers authored by Cavan Reilly

Since Specialization
Citations

This map shows the geographic impact of Cavan Reilly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cavan Reilly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cavan Reilly more than expected).

Fields of papers citing papers by Cavan Reilly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cavan Reilly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cavan Reilly. The network helps show where Cavan Reilly may publish in the future.

Co-authors

The 25 scholars most cited alongside Cavan Reilly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Cavan Reilly Line = papers co-authored together Cavan Reilly links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 146 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells
Hit paper breakdown →
2005806
2
Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues
Hit paper breakdown →
2014569
3
Glycerol monolaurate prevents mucosal SIV transmission
Hit paper breakdown →
2009539
4
The Lung Microbiome in Moderate and Severe Chronic Obstructive Pulmonary Disease
Hit paper breakdown →
2012355
5 2006293
6 2011259
7 2015239
8 2016210
9 2006208
10 2008197
11 2004185
12 2007162
13
Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial
Hit paper breakdown →
2022161
14 2008145
15 2012140
16 2006137
17 2008130
18 2006128
19 2006126
20 2009121

About Cavan Reilly

Cavan Reilly is a scholar working on Virology, Infectious Diseases, Periodontics, Management of Technology and Innovation and Ophthalmology, having authored 146 papers that have together received 8.3k indexed citations. Recurring topics across this work include HIV Research and Treatment (43 papers), Viral Infections and Outbreaks Research (18 papers), COVID-19 Clinical Research Studies (11 papers), Oral microbiology and periodontitis research (9 papers), HIV/AIDS drug development and treatment (6 papers), Gene expression and cancer classification (6 papers), Blood donation and transfusion practices (6 papers) and HIV/AIDS Research and Interventions (6 papers). The work is most often cited by research in Virology (3.9k citations), Infectious Diseases (1.1k citations), Periodontics (294 citations), Immunology (848 citations) and Ophthalmology (235 citations). Cavan Reilly has collaborated with scholars based in United States, United Kingdom and Liberia. Frequent co-authors include Ashley T. Haase, Timothy W. Schacker, Jacob D. Estes, John V. Carlis, Lijie Duan, Qingsheng Li, Stephen W. Wietgrefe, Jeffrey D. Lifson, Gregory J. Beilman and Chris H. Wendt. Their work appears in journals such as The Journal of Infectious Diseases, PLoS ONE, The Journal of Immunology, Journal of Clinical Investigation and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact